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Abstract
Background—Research has found some disparities between U.S. women with and without 
disabilities in receiving clinical preventive services. Substantial differences may also exist within 
the population of women with disabilities. The current study examined published research on Pap 
smears, mammography, and clinical breast examinations across disability severity levels among 
women with disabilities.
Methods: Informed by an expert panel, we followed guidelines for systematic literature reviews 
and searched MEDLINE, PsycINFO, and Cinahl databases. We also reviewed in-depth four 
disability- or preventive service-relevant journals. Two reviewers independently extracted data 
from all selected articles.
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Findings—Five of 74 reviewed publications of met all our inclusion criteria and all five reported 
data on Pap smears, mammography, and clinical breast examination. Articles classified disability 
severity groups by functional and/or activity levels. Associations between disability severity and 
Pap smear use were inconsistent across the publications. Mammography screening fell as 
disability level increased according to three of the five studies. Results demonstrated modestly 
lower screening, but also were inconsistent for clinical breast examinations across studies.
Conclusion—Evidence is inconsistent concerning disparities in these important cancer screening 
services with increasing disability levels. Published studies used differing methods and definitions, 
adding to concerns about the evidence for screening disparities rising along with increasing 
disability. More focused research is required to determine whether significant disparities exist in 
cancer screening among women with differing disability levels. This information is essential for 
national and local public health and health care organizations to target interventions to improve 
care for women with disabilities.
Introduction and Background
Research has established some disparities between women with and without disabilities in 
accessing clinical preventive services in the United States. A review of research published 
from 1990 through 2005 concluded that most studies were consistent in finding reduced 
routine breast and cervical cancer screening among women with disabilities than among 
those without (Wisdom et al., 2010). For example, Nosek and Gill (1998) reported that 
women with functional limitations were significantly less likely than others to have had a 
Pap test within the past 3 years. Among women age 40 years or older, those with functional 
limitations were significantly less likely to have had a mammogram within the past 2 years. 
Havercamp, Scandlin, and Roth (2004) found that women with developmental disabilities 
were significantly less likely than those with no disabilities to have ever received breast and 
cervical cancer screening. Notably, women with developmental disabilities were roughly 
five times more likely to have never received a Pap test (Havercamp et al., 2004). Wei, 
Findley, and Sambamoorthi (2006) demonstrated strikingly lower rates of breast and 
cervical cancer screening among women with disabilities compared with other women. 
More recently, Courtney-Long, Armour, Frammartino, and Miller (2011) noted that, 
compared with women without disabilities, women with disabilities were less likely to have 
received a mammogram within the past 2 years even when controlling for 
sociodemographic, social support, health status, and health care access variables.
This is not unexpected, given that the literature indicates that women with disabilities 
encounter a number of barriers to receiving clinical preventive services. These include 
barriers related to physical access, communication, professional support (Barr, Giannotti, 
Van Hoof, Mongoven, & Curry, 2008; Suzuki, Krahn, Small, & Peterson-Besse, in press), 
secondary or co-occurring medical conditions, and difficulty traveling to facilities (Suzuki et 
al., in press). Furthermore, women with multiple disabilities have reported more barriers to 
returning for regular mammograms than women with a single type of disability (Yankaskas 
et al., 2010). This latter finding highlights the fact that, in addition to differences between 
women with and without disabilities, there may be substantial differences within the 
population of women with disabilities. For example, given the complex barriers to clinical 
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preventive services encountered by women with disabilities, it can be hypothesized that 
severity of the disability may impact the extent to which women with disabilities are able to 
obtain screenings. Understanding these differences would help to target efforts to improve 
screening utilization among those most likely to be missed by general population 
interventions.
Although some research has studied differences between subgroups of women with 
disabilities (Cheng et al., 2001; Chevarley, Thierry, Gill, Ryerson, & Nosek, 2006; Diab & 
Johnston, 2004; Iezzoni, McCarthy, Davis, & Siebens, 2000; Iezzoni, McCarthy, Davis, 
Harris-David, & O’Day, 2001), a systematic examination of research in this area has not 
previously been conducted. The purpose of the present study was to systematically review 
existing research about disparities in U.S. women’s cancer screenings within the group of 
women with disabilities, by level of disability severity. We describe and qualitatively 
synthesize the findings across available studies. Specifically, we examine utilization rates of 
cervical cancer screening (Pap smears), mammograms, and clinical breast examinations. 
Further, the paper examines the strength of evidence to describe trends where the findings 
are sufficiently robust and identify areas where data are particularly sparse.
We used the recommendations for clinical preventive services established and updated by 
the U.S. Preventive Services Task Force (USPSTF, 2010) as the benchmark for this review. 
There are not separate recommendations for women with disabilities; thus, all women with 
disabilities should theoretically be receiving screenings with similar frequency as the general 
population of women. USPSTF recommendations are graded from A through D or I 
(insufficient evidence) based on expert assessment of the available evidence to support the 
recom mendations and magnitude of net benefit. These recommenda tions are intended to 
influence health care professional practices. The USPSTF recommendations relevant for our 
systematic review were from their publication dates and inclusive data were from 2002: The 
USPSTF recommended screening mammography with or without clinical breast 
examination every 1 to 2 years for women aged 40 or older (B grade recommendation; 
USPSTF, 2002). This was updated in 2009 to biennial screening mammography for women 
aged 50 to 74 (B grade) with decisions about screenings before age 50 to be guided by 
individual circumstances. Much of the research reviewed for the present review would have 
occurred when the 2002 recommendations for screenings beginning at age 40 and conducted 
every 1 to 2 years would have been in effect. For cervical cancer, the recommendation in 
2003 was to screen women who were sexually active and who had a cervix (A grade). See 
USPSTF for more information about more recent recommendations (USPSTF, 2009, 2012).
Methods
Conceptual Framework
This paper is derived from one of the foci of a larger study on disability disparities in health 
outcomes and preventive services funded by the National Institute on Disability and 
Rehabilitation Research. The larger study conducted a systematic scoping review of the 
literature to identify concentrations and gaps in the literature on within disability group 
disparities in utilization of clinical preventive services, using the following key question: 
What English language studies, conducted in the United States and presenting original 
Andresen et al. Page 3













analyses, have been published in the peer-reviewed literature from 2000 to 2009 that 
examine clinical preventive service use disparities among subgroups of people with 
disabilities ages 18 to 64? Because screening recommen-dations, healthcare delivery 
systems, and healthcare coverage vary remarkably across countries and age groups, our 
expert panel advised that we also limit our current review to studies about U.S. women 
between the ages of 18 and 64.
A systematic scoping review uses systematic review methods for study retrieval and review, 
but asks a broad key question and includes varied study designs with the intention of 
mapping the literature in an area of study (Arksey & O’Malley, 2005; Petticrew & Roberts, 
2006). The current study was a subanalysis on a topic identified from the larger scoping 
review: Utilization of women’s health services among women with disabilities by level of 
disability severity.
Disability was defined broadly, based on the conceptual domains of the International 
Classification of Disability, Functioning, and Health (ICF; World Health Organization, 
2001). The ICF defines disability as an umbrella term for impairments, activity limitations, 
or participation restrictions. Further, the ICF emphasizes that environmental factors interact 
with all of these constructs. We therefore included any disability or functional limitation, 
falling into physical, sensory, cognitive, mental health, social, or activity limitation 
functional categories. Detailed methods for the scoping review are reported elsewhere 
(Peterson, Walsh, Drum, & The Expert Panel on Health and Health Care Disparities among 
Individuals with Disabilities, Submitted). A brief summary of those methods are as follows. 
Figure 1 displays the flowchart of our processes in more detail.
Data Sources and Eligibility Criteria
We used systematic review methods, informed by guidelines outlined by Petticrew and 
Roberts (2006), the Cochrane Collaboration (Higgins & Green, 2008), and the PRISMA 
statement on reporting systematic reviews (Moher, Liberati, Tetzlaff, & Altman, 2009). All 
decisions setting the key question and definitions of concepts relevant to the question were 
guided by the Disability Rehabilitation Research Project Expert Panel on Health Disparities. 
Our comprehensive search strategy consisted of electronic searches of MEDLINE, 
PsycINFO, and Cinahl data-bases. Details of the electronic search strategy, which combined 
terms for disability populations with terms for clinical preventive services, are available 
elsewhere (Peterson et al., submitted). For disability, we included a total of 30 individual 
search terms and a global combined term (details available from authors). Example terms 
included broad categories such as disabled persons, activities of daily living, developmental 
disabilities, and mobility limitation, as well as more specific conditions such as paraplegia 
and blindness. Terms used to search for clinical preventive services included preventive 
health services, mass screening, and guideline adherence. The search strategy also included 
table of contents reviews of four disability or preventive service-relevant journals (Disability 
& Health Journal, Journal of Disability Policy Studies, Archives of Physical Medicine & 
Rehabilitation, and American Journal of Preventive Medicine), reviewing the reference lists 
of all articles included for extraction for potentially relevant titles, and articles nominated by 
members of the Expert Panel. Inclusion criteria were: published in English-language peer-
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reviewed journals from 2000 to 2009; about adults aged 18 to 64 who have a disability and 
reside in the United States; examination of use of clinical preventive services. Articles 
included in the review could describe either observational or intervention research and were 
not limited by study design. Articles included in the review were required to present original 
analyses of data, and review articles were not included. Articles were included that 
presented relevant data, even if disparities in clinical preventive service use by people with 
disabilities was not a study focus. Review for inclusion was conducted at the abstract and 
full-text levels. Exclusion at the abstract level was conducted in a hierarchical sequential 
fashion. Once an article was excluded for one reason, the article was not subjected to review 
for additional sequential reasons. The sequential exclusion was as follows: 1) non-English 
language publications; 2) outside of 2000 to 2009 date range; 3) population located outside 
of the United States; 4) non-peer reviewed publications; 5) article did not include original 
data; 6) article was non-target age range; 7) article did not examine utilization of clinical 
preventive services; 8) non-disability target population; and 9) did not examine disparities. 
For example, among 3,084 articles reviewed at the abstract level, we excluded 546 because 
they were not about U.S.-based populations. However, had they been retained at that step, 
many would likely have failed to meet subsequent inclusion criteria. At the abstract level, 
there was a 10% overlap across reviewers to monitor inter-rater reliability and reviewer 
drift. Dual independent review was conducted of all articles at the full-text level. The 
inclusion and exclusion process for the parent review had acceptable agreement for 
inclusion among reviewers: 98.9% agreement for abstracts and 89.6% agreement for full-
text reviews. All inclusion discrepancies were resolved by consensus.
Data Extraction
Data were extracted from each article using a form developed for this study. Two reviewers 
independently extracted data relevant to the review key questions from all included articles, 
with all data discrepancies resolved by consensus. We extracted all data that examined 
potential within-disability group differences in use of any clinical preventive services. A 
number of individual and system-level factors were extracted to examine for possible 
disparity evidence, including disability severity. For articles that the reviewers concluded 
were unclear for the relevant evidence, they asked for review by at least one member of the 
Expert Panel to address specific questions before finalizing the coded information.
Current Study and Analysis
From the results of the systematic scoping review (Peterson et al., submitted), we observed 
that utilization of women’s health services was the only area with sufficient data to warrant 
further analysis of evidence for subgroup disparity. During our initial scoping review, 18 
articles met initial criteria (See Figure 1 [Allen, Wieland, Griffin, & Gozalo, 2009; Armour, 
Swanson, Waldman, & Perlman, 2008; Burns, 2009; Carney, Allen, & Doebbeling, 2002; 
Cheng et al., 2001; Chevarley et al., 2006; Coughlin, Long, & Kendall, 2002; Daumit, 
Crum, Guallar, & Ford, 2002; Diab & Johnston, 2004; Folsom et al., 2002; Havercamp et 
al., 2004; Iezzoni et al., 2000; Iezzoni et al., 2001; Kroll & Neri, 2004; Neri, Bradley, & 
Groce, 2007; Salsberry, Chipps, & Kennedy, 2005; Schenck et al., 2009; Wei et al., 2006]). 
We reviewed the set of articles that included women’s health topics (n = 10) for relevance 
and found that only one factor examining potential within-disability group differences—
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disability severity—had sufficient data to justify synthesis. For the present study, we 
included all articles coded as examining utilization of mammography, clinical breast 
examination, or cervical cancer screening and coded as examining differences in utilization 
by level of disability severity. For each publication included in our study, we report 
descriptive data (including definition of disability and of disability severity subgroups) and 
study findings (both prevalence and adjusted odds ratios [AOR], as available). In several 
cases, disability severity groups were compared with a common non-disability referent 
group, rather than to each other. In these cases, we indirectly compared disability groups to 
each other to determine whether these differences reflected disability severity trends.
Because studies were heterogeneous in objectives and outcomes, we did not systematically 
rate individual study quality. One of the authors (E.M.A.) reviewed each article further for 
assessment of the data source, services and classifications, and analyses (e.g., statistical 
adjustments). These written assessments were reviewed by all authors for consideration of 




Results of the data abstraction process are summarized in Table 1. As noted, there were five 
studies that met our criteria for inclusion in this review, and all five reported data and 
analysis on receipt of Pap smears, mammography, and clinical breast examination (Cheng et 
al., 2001; Chevarley et al., 2006; Diab & Johnston, 2004; Iezzoni et al., 2000; Iezzoni et al., 
2001). Three studies used data from the 1994-1995 National Health Interview Survey-
Disability Supplement (NHIS-D; Chevarley et al., 2006; Iezzoni et al., 2000; Iezzoni et al., 
2001), one used data from the Behavioral Risk Factor Surveillance System (BRFSS) 
analyzing data from 1998 (13 states) and 2000 (18 states) separately (Diab & Johnston, 
2004), and one study used multiple sclerosis (MS) patient data from three U.S. health care 
systems (Cheng et al., 2001). Demographically, all studies included a large majority of 
White women.
Study classifications of disability severity groups were generally functional and/or activities 
based as defined by the ICF; however, no two studies used the same definitions. Cheng and 
colleagues (2001) compared women with MS across three ambulatory mobility levels. 
Chevarley and colleagues (2006) categorized women from the NHIS-D using a broad array 
of physical functional limitations and analyzed women with none (women without 
disability), one or two, and three or more limitations. Diab & Johnston (2004) used three 
questions from the BRFSS starting with “any limitations” and then asked women with 
limitations whether they needed assistance with routine or personal care tasks. Responses 
about assistance needs were used to classify women as having indicators of problems with 
instrumental activities of daily living and activities of daily living. Both BRFSS samples of 
women were then classified as having no limitation, mild disability (limitation only), 
moderate disability (limitation and instrumental activities of daily living), or severe 
disability (limitation and activities of daily living). Iezzoni and colleagues (2000) classified 
women by levels of mobility problems, from no difficulty (women without disability), 
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through three levels of difficulty (minor, moderate, major) based on walking, stair climbing, 
or use of a wheelchair or scooter. Iezzoni and colleagues (2001) also examined disability 
severity among subgroups of physical functional problems. Functional groups included 
women with lower extremity mobility problems, upper extremity mobility problems, and 
problems using hands. Each group was further categorized by two levels (some difficulties 
vs. major/significant difficulties) and compared with a reference group of all other women 
without that specific disability.
Study Results
Pap smear—Across all five studies, there were inconsistent findings for the effect of 
disability severity on Pap smear use. The strongest results suggesting disparity were from 
among women with MS. Cheng and colleagues (2001) demonstrated a strong gradient 
(disability severity trend). Both unadjusted percentages and AOR results demonstrated 
greater proportions of women screened in the last 3 years with decreasing disability severity, 
comparing women who were not ambulatory (68% screened, reference category) with 
women who were ambulatory with help (79%; AOR, 2.11) and fully ambulatory (93%; 
AOR, 5.32). In a similar vein, Chevarley and colleagues (2006) demonstrated that age 
adjusted prevalence of recent Pap smear (within the last year) declined across functional 
groups (0 limitations, 49.6% screened; 1 2 limitations, 47.9%; 3 or more limitations, 45.1%). 
However, there were no clear trends representing a severity gradient or a “threshold” for 
some level of limitation across increasingly longer periods for Pap smears (e.g., within 1 3 
years, longer than 3 years, never). The results also were not subjected to a multivariate 
comparison adjusting for possible confounders other than age. Data from the BRFSS 
surveys (Diab & Johnston, 2004) also examined Pap smears within the last 3 years. 
Although the unadjusted results showed some evidence of disparity for women with 
disability compared with women without disability, there was not a clear disability severity 
gradient. In addition, between the 2 years of data that the study analyzed separately, adjusted 
results suggested that for the 18 states included in the later BRFSS 2000 analysis, women 
with the highest level of disability severity were more likely to have received a Pap smear 
compared with other women with less severe disability and also compared with women 
without disability (the AOR for women with severe disability was 1.07 compared with 
women without disability; Table 1). Both studies conducted by Iezzoni and colleagues 
(Iezzoni et al., 2000; Iezzoni et al., 2001) demonstrate some indirect evidence of a 
“threshold” effect, where the most severe disability level was associated with lower Pap 
smear rates for women with mobility problems. However, the effect was absent, perhaps 
even reversed, for women whose disability was limited to their hands.
Mammography—Mammography was reduced for women with increasing levels of 
disability severity for three of the five studies. However, data from the NHIS-D using 
functional limitations (Chevarley et al., 2006) did not demonstrate any pattern of disparity 
across disability severity or increasing durations since last mammogram. Similarly, BRFSS 
data analysis from 2000 (Diab & Johnston, 2004) showed no effect of disability or disability 
severity for mammography within the last 2 years. Cheng and colleagues (2001) 
demonstrated a strong severity threshold effect for women who were not ambulatory 
(highest level of severity) compared with other women with MS. Data from the 1998 
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BRFSS demonstrated both unadjusted and adjusted comparisons showing decreasing 
mammography with increasing severity of disability (Diab & Johnston, 2004). Using 
different definitions of disability severity in the NHIS-D data, Iezzoni and co-workers 
(Iezzoni et al., 2000; Iezzoni et al., 2001) demonstrated an effect of increasing severity and 
decreasing mammography in the past 2 years in both analyses of the NHIS-D.
Clinical breast examination—Evidence for an effect of disability severity for clinical 
breast examination was evident in the study of women with MS. Cheng and colleagues 
(2001) examined clinical breast examination within the last year, and showed striking crude 
and adjusted disparities for women with increasing mobility problems. Women who were 
ambulatory were most likely to have received a clinical breast examination (86%), followed 
by women who were ambulatory with help (79%) and women who were not ambulatory 
(69%). Demographic and comorbidity-adjusted analyses also demonstrated this severity 
gradient pattern. Analyses based on the BRFSS demonstrated an effect of disparity in 
clinical breast examination in the past year across disability severity in both sets of 
unadjusted analyses (1998 and 2000 BRFSS states), but very weak or absent patterns in 
adjusted analyses (Diab & Johnston, 2004). In analysis of the NHIS D for mobility severity 
levels, Iezzoni and colleagues (2000) demon strated decreasing clinical breast examinations 
with increasing disability severity; however, the study did not include adjusted results. 
Using categories of mobility disability, Iezzoni and colleagues (2001) also demonstrated a 
modest effect of reduced clinical breast examination for more severe disability in both lower 
extremity and upper extremity mobility disability groups. However, the analysis of women 
with hand disability showed a modest reversed effect: women with major disability were 
more like the comparison group than women with some disability (AOR, 0.7 for the latter; 
0.90 for the former).
Discussion
The five studies included in this review each contributed results relevant to our question 
about whether severity of disability is a risk factor for reduced clinical preventive services 
for women. However, each of the studies was designed for its own scientific question using 
their own disability definition. Overall, the five articles stated purposes and used methods 
that were not a direct match with our systematic review key question. There were varied 
definitions of disability and severity, and even differences in indicators of screening 
guidelines. In one case (Chevarley et al., 2006), mammography and clinical breast 
examination screening were examined for women aged 30 and older. Although guidelines 
from different sources have differed by age (age 40, 50, stopping at older ages) and by 
frequency, no recommendations suggest that mammography begin at age 30. Each study 
used a different method to define severity or level of disability, although they shared some 
common ground based on some form of physical function (e.g., mobility levels) or activity 
(e.g., self-care). The fact that three studies (Chevarley et al., 2006; Iezzoni et al., 2000; 
Iezzoni et al., 2001) all analyzed one data set (NHIS-D) but arrived at slightly differing 
findings demonstrates the importance of how disability severity is defined. These 
differences in definitions, as well as other differences between samples, produced problems 
and complexity in interpreting evidence patterns for our question about disability severity. 
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For example, one study was based on a relatively small patient sample with healthcare 
coverage (Cheng et al., 2001; U.S. Department of Health and Human Services, 2000) and 
the other four were based on larger, community-dwelling, pop ulation-based samples. An 
additional barrier to reaching a clear conclusion was that only the crude (or minimally age-
adjusted) prevalence figures provided direct evidence in some studies because the referent 
category for most adjusted analyses was women without disabilities. However, our focus 
was on comparisons among women with disabilities, looking at effects of disability severity.
In addition to the heterogeneity of study methodologies, there were differences in results for 
our question about disparity by disability severity. There was some evidence for disparity by 
disability severity for all three preventive services. However, the evidence varied by 
preventive service and whether the evidence supported a trend with disability severity across 
categories, or if there was evidence only for women with the highest level of impairment. 
Because national and local public health and healthcare organizations need to understand 
whether and where disparities exist, there is a considerable need for more (and more 
focused) research about cancer screening disparity among women with disability.
Implications for Policy
As noted, our review was hampered by having few articles that focused on and reported data 
on subgroups of women with disabilities. Whereas federal funding agencies support and 
request reporting data by subgroups (e.g., by gender or race/ ethnicity), there have been no 
previous policies that require or strongly support data on disability status (or subgroups) as a 
group with disparities. Without these policies, and/or funding initiatives that specifically 
request such analysis, there may continue to be sparse attention to disparities in women’s 
health within disability.
Differences in definition of disability created a significant obstacle to collating data and 
making comparisons across studies. Healthy People 2010 (U.S. Department of Health and 
Human Services, 2000) and again Healthy People 2020 (U.S. Department of Health and 
Human Services, 2010) had as one of their objectives to include a standard definition of 
disability in all surveillance. The Affordable Care Act (U.S. Department of Health and 
Human Services, n.d.a) provides promise to address this problem in two sections. First, 
Section 4302, “Under-standing Health Disparities” calls for routine inclusion of six 
disability identifier questions in federally funded or supported public health programs, 
activities and surveys (Madans, Loeb, & Altman, 2011). This led to standards for disability 
identification being established by the U.S. Department of Health and Human Services (U.S. 
Department of Health and Human Services, Office of Minority Health, 2011) that should 
standardize data collection for disability, and increase ability to distinguish among type (if 
not severity) of functional limitations in the future. Researchers are encouraged to add 
questions that would assess severity of disability (e.g., difficulty with complex activities 
entailed in performance of social roles; Altman & Bernstein, 2008). Further, Section 4203 of 
the Affordable Care Act requires establishing standards for accessible medical equipment 
like radiology equipment, examination tables, and weight scales. This requirement is 
anticipated to increase access of women, particularly with mobility limitations, to routine 
clinical procedures (U.S. Department of Health and Human Services, n.d.b). To monitor and 
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evaluate these changes, and to continue to promote screening access for women, we will 
need population-level data. Although our report highlights the methods and data sources, 
and Affordable Care Act-driven changes promise to improve data and access, there may still 
need to be a funder incentive to generate interest in examining data for disability status, 
type, and severity.
Social factors are increasingly recognized as important contributors to health. Social 
determinants refer to the social circumstances in which people live their lives (World Health 
Organization, 2013) and are often measured in terms of education, income, urban/rural 
residence, health care access, transportation, and environmental safety factors. These social 
factors are as relevant for people with disabilities as the general population, and 
environmental access is especially important for people with disabilities, who can be 
excluded from participation through physical, attitudinal, or policy barriers. Our review 
sought to examine disparities related to social determinants in addition to disability severity, 
but these factors were not included in many of the studies we reviewed. Even where these 
factors were included (e.g., age, education), they were used as covariates in analyses, and 
the effects of social determinants were not examined for their contribution to health service 
utilization. Future research should begin to examine the contribution of these social factors 
to a range of health outcomes, including use of clinical preventive services.
In conclusion, there is modest evidence for disparity in all three cancer clinical preventive 
screenings with increasing disability severity or among women with the most severe 
disability (threshold effect). The evidence from these five studies is far from conclusive. 
Heterogeneity of samples, definitions of disability severity, and choice of comparison 
groups adds to our caution in concluding there is a pattern of evidence for decreased 
screening with increased disability severity.
The field requires much more targeted analysis and consistent definitions to generate 
stronger evidence. All of the available studies and most future research will be observational 
in design. The descriptive epidemiologic research needs to develop to the level that there is 
some consistency of the scientific story, one of the core concepts of concluding causal 
inference in observational (versus interventional) research (Rothman, Greenland, & Lash, 
2008). There are at least two avenues that can contribute to this development of evidence. 
One is for published research to provide sufficient detail on subgroups of people with 
disabilities that there are, at a minimum, crude estimates of the patterns of use of preventive 
services. Because disability is not often the sole focus of such studies, the samples that meet 
some classification of disability may be small and therefore not included in descriptive 
tables. Second, because descriptive results in observational studies are very likely to be 
confounded by other social determinant factors that are associated with disparities (e.g., 
education), there need to be publications that focus specifically on women with disabilities 
and thoroughly analyze the results to address disparities among subgroups. The majority of 
this work may be from existing research (secondary analyses of clinical research, healthcare 
administrative data, etc), and targeted analyses of large federal data with sufficient numbers 
of women with disabilities (e.g., NHIS, BRFSS, the Medical Expenditure Panel Study). All 
of these samples have special problems in addressing the question we raised in this article 
(samples, classifications, etc.). However, given that the goal is to understand whether there 
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is consistency of the evidence, these differences might build the picture precisely because an 
emerging pattern would suggest a fairly consistent pattern among heterogeneous studies. In 
addition, a careful examination of the variations could explain why some analyses (outliers) 
do not fit the scientific picture. The essential first step is to have sufficient published 
research, with consistent definitions and outcomes, to begin to combine evidence.
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Table 1
Systematic Review of Disparities among Women with Disabilities for Cancer Clinical Preventive Screenings













Disability Severity Subgroups Results
Cervical cancer screening (Pap 
smear)
 Cheng, 2001 MS patients; N 
= 692;




care in 3 U.S. health
care systems
Past 3 years Mobility level % AOR
 Ambulatory 93 5.32
 Ambulatory with help 79 2.11
 Not ambulatory 68 REF






NHIS-D (1994–1995) Functional limitations (n)
% in levels
†
0, 1–2, ≥3 0 1–2 ≥3
Within past year 49.6 47.9 45.1
 1–3 years 24.9 24.6 26.6
 >3 years 16.2 22.0 19.0
 Never 5.7 2.7 4.1
 Unknown 3.7 2.8 5.3
 Diab, 2004 N = 24,289*; 
Age ≥ 18;
78% White
BRFSS 1998; 13 
states
Past 3 years Activity limitation % AOR
 No limitation 83.8 REF
 Mild disability 78.8 0.98
 Moderate disability (IADL) 72.7 0.99
 Severe disability (ADL) 72.9 0.94
N = 35,341*; 
Age ≥ 18;
68% White
BRFSS 2000; 18 
states
Activity limitation % AOR
 None 84.5 REF
 Mild disability 80.7 1.00
 Moderate disability (IADL) 77.5 0.99
 Severe disability (ADL) 81.9 1.07
 Iezzoni, 2000 N = 77,437; 
Age 18–75
NHIS-D (1994–1995) Past 3 years Mobility problems % AOR
 Major: Unable to walk, 
climb
  stairs, stand, wheelchair/
  scooter
63.3 0.6
Moderate: A lot of difficulty 79.6 1.3
 Minor: Some difficulty 79.4 1.2
 None: No difficulty 81.4 REF







NHIS-D (1994–1995) Past 3 years 1. Lower extremity mobility %
AOR
‡
 Major/significant difficulty 67.7 0.6
 Some difficulty 80.3 1.2
2. Upper extremity mobility %
AOR
‡
 Major/significant difficulty 72.0 0.9
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Disability Severity Subgroups Results
 Some difficulty 70.4 1.1
3. Using hands %
AOR
‡
 Major/significant difficulty 72.5 0.9
 Some difficulty 70.8 0.7
Mammography
 Cheng, 2001 MS N = 245; 
Age ≥ 50;
86% White of 
total N
Received outpatient
care in 3 U.S. health
care systems
Past 2 years Mobility level % AOR
 Ambulatory 89 3.24
 Ambulatory with help 90 3.37
 Not ambulatory 71 REF








30; 76% White 
in total N




Within the past 0, 1–2, ≥3 29.6 32.3 28.2
year
 1–2 years 16.1 12.6 15.9
 >2 years 14.8 16.6 16.3
 Never 35.9 35.2 36.5
 Unknown 3.5 3.2 3.1
 Diab, 2004 N = 10,356*; 
Age ≥ 50;
78% White of 
total
sample N
BRFSS 1998; 13 
states
Past 2 years Activity limitation % AOR
 None 77.7 REF
 Mild disability 77.2 1.03
 Moderate disability (IADL) 71.6 0.99
 Severe disability (ADL) 68.4 0.84
N = 14,522*; 
age ≥ 50;
68% White of 
total
sample N
BRFSS 2000; 18 
states
Activity limitation % AOR
 None 82.2 REF
 Mild disability 80.0 1.00
 Moderate disability (IADL) 78.4 0.97
 Severe disability (ADL) 81.7 1.11





ages; age ≥ 50
NHIS-D (1994–1995) Past 2 years Mobility problems % AOR
 Major: Unable to walk, 
climb
  stairs, stand, wheelchair/
  scooter
45.3 0.7
 Moderate: A lot of difficulty 51.5 0.9
 Minor: Some difficulty 58.3 1.0
 None: No difficulty 63.5 REF





ages; age ≥ 50
NHIS-D (1994–1995) Past 2 years 1. Lower extremity mobility %
AOR
‡
 Major/significant difficulty 49.9 0.7
 Some difficulty 55.8 1.0
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Disability Severity Subgroups Results
2. Upper extremity mobility %
AOR
‡
 Major/significant difficulty 48.8 0.8
 Some difficulty 56.4 1.1
3. Using hands %
AOR
‡
 Major/significant difficulty 41.7 0.6
 Some difficulty 52.6 0.8
Clinical breast examination
 Cheng, 2001 MS N = 245; 
age ≥ 50;
86% White of 
total N
Received outpatient
care in 3 U.S. health
care systems
Past year Mobility level % AOR
 Ambulatory 86 3.62
 Ambulatory with help 79 1.83
 Not ambulatory 69 REF







ages; age ≥ 30;
76% White in 
total N




Within the past 0, 1–2, >3 53.7 51.7 54.4
year
 1–2 years 18.7 17.9 16.4
 >2 years 18.5 20.3 20.3
 Never 5.0 7.4 5.1
 Unknown 4.1 2.7 3.8
 Diab, 2004 N = 10,466*; 
age ≥ 50;
78% White in 
total
sample N
BRFSS 1998; 13 
states
Past year Activity limitation % AOR
 None 67.4 REF
 Mild disability 64.2 0.98
 Moderate disability (IADL) 60.6 0.96
 Severe disability (ADL) 59.3 0.96
N = 14,636*; 
age ≥ 50;
68% White in 
total
sample N
BRFSS 2000; 18 
states
Activity limitation % AOR
 None 67.9 REF
 Mild disability 63.0 0.93
 Moderate disability (IADL) 63.6 0.96
 Severe disability (ADL) 60.1 1.05





ages; age ≥ 50
NHIS-D (1994–1995) Past 2 years Mobility problems % (no AOR)
 Major: Unable to walk, 
climb
  stairs, stand, wheelchair/
  scooter
63.9
 Moderate: A lot of difficulty 65.4
 Minor: Some difficulty 71.7
 None: No difficulty 75.7
 Iezzoni, 2001 N = 77,762; 
includes
NHIS-D (1994–1995) Past 2 years 1. Lower extremity mobility %
AOR
‡
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ages; age ≥ 50
 Major/significant difficulty 67.4 0.6
 Some difficulty 69.2 1.2
2. Upper extremity mobility %
AOR
‡
 Major/significant difficulty 69.3 0.9
 Some difficulty 67.0 1.1
3. Using hands %
AOR
‡
 Major/significant difficulty 69.3 0.9
 Some difficulty 64.8 0.7
Abbreviations: ADL, activities of daily living; AOR, adjusted odds ratio; BRFSS, Behavioral Risk Factor Surveillance System; CI, confidence 
interval; FL, functional limitation; IADL, Instrumental ADL; M, mean; MS, multiple sclerosis; NHIS-D, National Health Interview Survey-
Disability supplement; REF, referent group; RR, relative risk.
*
Sample n’s for this study are for the prevalence figures. Adjusted models had fewer subjects.
†
Prevalence figures for this study are age adjusted.
‡
Reference group for comparisons in this study are all women without the specific disability in that cell.
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